Brief: Proteomics International Laboratories Says Signed A Licence Agreement
Dec 20 (Reuters) - Proteomics International Laboratories
Ltd PIQ.AX :
* SIGNED A LICENCE AGREEMENT FOR SALE OF PROMARKERD
PREDICTIVE
TEST FOR DIABETIC KIDNEY DISEASE IN CHILE
* DEAL EXPANDS LONG-STANDING PARTNERSHIP WITH BIOTECHNOLOGY
COMPANY OMICS GLOBAL SOLUTIONS
Source text for Eikon: ID:nASX271vlf
Further company coverage: PIQ.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Proteomics International Laboratories
See all newsBrief: Proteomics International Laboratories Launches Share Purchase Plan To Raise Up To A$5 MLN
Australia's Proteomics slips to four-month low on discounted share sale plan
Brief: Proteomics International Laboratories Posts FY Loss Attributable A$8.6 Million
Brief: Proteomics International Laboratories Signs Agreement With Healius For Promarker Portfolio
Australia's Proteomics International soars on distribution deal with Healius